Boston Scientific (NYSE:BSX) is set to report its Q4 2018 earnings on February 6, and we expect the company to post mid-single-digit revenue growth, and adjusted earnings per share to grow in high single-digits. The company will likely see steady growth in all segments, primarily the MedSurg segm...